Knockdown of natriuretic peptide receptor-A enhances receptor C expression and signalling in vascular smooth muscle cells

Cardiovasc Res. 2012 Feb 1;93(2):350-9. doi: 10.1093/cvr/cvr319. Epub 2011 Nov 29.

Abstract

Aims: Natriuretic peptide receptor-A (NPR-A) knockout mice exhibited an increased blood pressure that may also be attributed to the up-regulation of NPR-C and associated signalling; however, the interaction between the two receptors has not been investigated. In the present study, we investigated the effect of knockdown of NPR-A using NPR-A antisense (AS) on the expression of NPR-C and adenylyl cyclase (AC) signalling in A10 vascular smooth muscle cells (VSMC).

Methods and results: The receptor and G protein expression was determined by western blotting, and AC activity was determined by measuring [(32)P]cAMP formation from [α-(32)P]ATP. Treatment of A10 VSMC with NPR-A AS decreased NPR-A and enhanced NPR-C expression without altering the levels of angiotensin II AT1 and muscarinic M2 receptors. In addition, siRNA-NPR-A also resulted in the up-regulation of NPR-C. The re-expression of NPR-A in AS-treated cells reversed the enhanced expression of NPR-C to control levels. In addition, NPR-C-, AT1, and M2 receptor-mediated inhibition of AC and Giα protein expression was enhanced in AS-treated cells, whereas NPR-A-mediated cyclic GMP (cGMP) formation and Gsα-mediated stimulation of AC were significantly reduced. Pertussis toxin treatment attenuated the AS-induced enhanced inhibition of AC to control levels. Furthermore, the enhanced levels of NPR-C and Giα proteins were reversed to control levels by 8-bromo-cGMP (8Br-cGMP) and PD98059, an MEK inhibitor. In addition, 8Br-cGMP also attenuated AS-induced enhanced ERK1/2 phosphorylation to control levels.

Conclusion: These results demonstrate that knockdown of NPR-A up-regulates the expression of NPR-C, Giα proteins, and NPR-C-linked AC signalling and suggests a cross-talk between NPR-A and NPR-C.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenylyl Cyclase Inhibitors
  • Adenylyl Cyclases / physiology
  • Animals
  • Cells, Cultured
  • Cyclic GMP / analysis
  • GTP-Binding Protein alpha Subunits, Gi-Go / physiology
  • MAP Kinase Signaling System
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / metabolism*
  • Myocytes, Smooth Muscle / metabolism*
  • Pertussis Toxin / pharmacology
  • RNA, Small Interfering / genetics
  • Rats
  • Receptor Cross-Talk*
  • Receptor, Angiotensin, Type 1 / analysis
  • Receptor, Muscarinic M2 / analysis
  • Receptors, Atrial Natriuretic Factor / analysis
  • Receptors, Atrial Natriuretic Factor / physiology*
  • Signal Transduction / physiology*

Substances

  • Adenylyl Cyclase Inhibitors
  • RNA, Small Interfering
  • Receptor, Angiotensin, Type 1
  • Receptor, Muscarinic M2
  • Pertussis Toxin
  • GTP-Binding Protein alpha Subunits, Gi-Go
  • Adenylyl Cyclases
  • Receptors, Atrial Natriuretic Factor
  • atrial natriuretic factor receptor A
  • atrial natriuretic factor receptor C
  • Cyclic GMP